You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

18F-fluciclovine

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Portland (Fluciclovine PET/CT)

Not yet recruiting
  • Prostate Cancer
  • Fluciclovine PET/CT
  • Portland, Oregon
    Oreogn Health & Science University
Feb 1, 2023

PET-MR-PSA Prostate Cancer Recidive Study

Active, not recruiting
  • Prostate Cancer Recurrent
    • Trondheim, Norway
      St Olavs Hospital, PET center
    Mar 1, 2022

    Secondary Malignant Tumor of Brain and Cerebral Meninges Trial in Cleveland (18F-fluciclovine, PET/CT of the brain)

    Completed
    • Secondary Malignant Neoplasm of Brain and Cerebral Meninges
    • 18F-fluciclovine
    • PET/CT of the brain
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
    May 3, 2021

    Prostate Adenocarcinoma Trial in Tucson (F-18 fluciclovine-PET/CT scan)

    Completed
    Has Results
    • Prostate Adenocarcinoma
    • F-18 fluciclovine-PET/CT scan
    • Tucson, Arizona
      University of Arizona
    Aug 12, 2022

    Malignant Tumor of Prostate Trial in Cleveland ([F-18] NaF PET/CT, [F-18] fluciclovine PET/CT)

    Withdrawn
    • Malignant Neoplasm of Prostate
    • [F-18] NaF PET/CT
    • [F-18] fluciclovine PET/CT
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Mar 21, 2022

    Prostate Cancer Trial in Los Angeles (18F-Fluciclovine)

    Completed
    Has Results
    • Prostate Cancer
    • 18F-Fluciclovine
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Feb 2, 2021

    Brain Metastases, Cancer, Gliomas Trial in Houston (F18 Fluciclovine, Standard of Care)

    Not yet recruiting
    • Brain Metastases
    • +3 more
    • F18 Fluciclovine
    • Standard of Care
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 11, 2022

    Cervical Cancer, Uterine Cancer Trial in Pittsburgh (18F fluciclovine, 18F fluciclovine PET)

    Terminated
    Has Results
    • Cervical Cancer
    • Uterine Cancer
    • 18F fluciclovine
    • 18F fluciclovine PET
    • Pittsburgh, Pennsylvania
      UPMC Presbyterian - MR Research Center
    Oct 6, 2020

    Recurrent Prostate Carcinoma Trial in Los Angeles (procedure, drug, other)

    Completed
    • Recurrent Prostate Carcinoma
    • Computed Tomography
    • +4 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Oct 12, 2020

    Prostate Cancer Trial in Birmingham ([18F] Fluciclovine PET/MRI, [18F] fluciclovine)

    Completed
    Has Results
    • Prostate Cancer
    • [18F] Fluciclovine PET/MRI
    • [18F] fluciclovine
    • Birmingham, Alabama
      University of Alabama at Birmingham Medical Center
    Feb 26, 2020

    Prostate Cancer Recurrent Trial in Nijmegen (F18-fluciclovine PET/CT, F18-PSMA-1007 PET/CT)

    Unknown status
    • Prostate Cancer Recurrent
    • F18-fluciclovine PET/CT
    • F18-PSMA-1007 PET/CT
    • Nijmegen, Netherlands
      Radboudumc
    Jan 23, 2020

    [18F]Florbetazine for Beta Amyloid PET Imaging in Alzheimer's

    Recruiting
    • Alzheimer's Disease
    • Beijing, China
      Department of Nuclear Medicine, Peking Union Medical College Hop
    Nov 19, 2023

    Glioblastoma Trial in Houston (Computed Tomography, Fluciclovine F18, Positron Emission Tomography)

    Unknown status
    • Glioblastoma
    • Computed Tomography
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 25, 2019

    18F-FAPI, 18F-FDG, Pancreas Adenocarcinoma Trial in Hangzhou (18F-FAPI, 18F-FDG)

    Completed
    • 18F-FAPI
    • +4 more
    • Hangzhou, Zhejiang, China
      the First Affiliated Hospital, School of Medicine, Zhejiang Univ
    May 31, 2023

    Breast Cancer, Breast Carcinoma, Metastatic Breast Cancer Trial in New York (18F-FDG PET/CT, [18F]-Fluoro-2-Deoxy-D-Glucose and

    Recruiting
    • Breast Cancer
    • +4 more
    • 18F-FDG PET/CT
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 17, 2023

    Tumor, Solid Trial in Nanchong (Radiation: 18F-AlF-FAPi-04, Radiation: 18F-FDG)

    Recruiting
    • Tumor, Solid
    • Radiation: 18F-AlF-FAPi-04
    • Radiation: 18F-FDG
    • Nanchong, Sichuan, China
      Affiliated Hospital of North Sichuan Medical College
    Nov 6, 2023

    Study of 18F-FAPI Applied to Gastrointestinal Cancer

    Not yet recruiting
    • Gastrointestinal Cancer
    • 18F-FAPI and 18F-FDG PET/CT
    • (no location specified)
    Mar 28, 2023

    Advanced Non Small Cell Lung Cancer Trial ([18F]F-AraG)

    Not yet recruiting
    • Advanced Non Small Cell Lung Cancer
    • (no location specified)
    Oct 24, 2023

    NSCLC Trial in Iowa City ([18F]F-ARAG PET)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • [18F]F-ARAG PET
    • Iowa City, Iowa
      University of Iowa Hospitals and Clinics
    Oct 10, 2023

    The Novel 18F-labeled MAO-B PET Tracer Study in Parkinsonism

    Recruiting
    • Parkinson Disease
    • Hefei, Anhui, China
      The First Affiliated Hospital of China University of Science and
    Aug 17, 2023

    Diagnostic Agent Adverse Reaction, Radiation Exposure Trial in New Haven (18F-LY3950321, PET Scan)

    Recruiting
    • Diagnostic Agent Adverse Reaction
    • Radiation Exposure
    • New Haven, Connecticut
      Invicro, LLC
    Mar 20, 2023

    Clear Cell Sarcoma of Soft Tissue Trial in Wuhan (18F-PFPN)

    Recruiting
    • Clear Cell Sarcoma of Soft Tissue
    • Wuhan, Hubei, China
      China, Hubei Province
    Jul 19, 2023

    Parkinson Disease, Dementia With Lewy Bodies, MSA - Multiple System Atrophy Trial in Leuven, Gent ([18F]-MFBG PET CT,

    Not yet recruiting
    • Parkinson Disease
    • +3 more
    • [18F]-MFBG PET CT
    • +3 more
    • Leuven, Vlaams-Brabant, Belgium
    • +1 more
    Oct 31, 2023

    High Risk Prostate Carcinoma Trial in Gyeonggi-do, Seoul, Soeul ([F-18]Florastamin)

    Recruiting
    • High Risk Prostate Carcinoma
    • Gyeonggi-do, Korea, Republic of
    • +5 more
    Jun 29, 2023

    Cerebral Gliosis, Positron Emission Tomography Trial in Shanghai ([18F]BF3-BPA Injection for PET Imaging)

    Recruiting
    • Cerebral Gliosis
    • Positron Emission Tomography
    • [18F]BF3-BPA Injection for PET Imaging
    • Shanghai, China
      Huashan Hospital
    Nov 19, 2023